Theodore Bouras1, Vasileios Bitas1, Peter Fennema2, Panagiotis Korovessis3. 1. Orthopaedic Department, General Hospital of Patras, Tsertidou 1, 26335, Patras, Greece. 2. AMR Advanced Medical Research, Hofenstrasse 89b, 8708, Männedorf, Switzerland. 3. Orthopaedic Department, General Hospital of Patras, Tsertidou 1, 26335, Patras, Greece. korovess@otenet.gr.
Abstract
PURPOSE: While cemented total knee arthroplasty (TKA) is currently the gold standard for primary osteoarthritis, cementless component fixation has achieved increasingly comparable outcomes due to improvements in both implant designs and surgical technique. Long-term outcomes and survivorship with the TC-Plus cementless, titanium plasma-coated TKA system without patella resurfacing were evaluated. METHODS: A homogenous population of 171 consecutive patients who received 206 primary TC-Plus TKAs without patella resurfacing over a 19-year period was retrospectively reviewed. Knee Society Clinical Rating System (KSCRS) scores were obtained, and radiographic evaluation was performed after a mean follow-up of 13.2 ± 8.4 years. Survivorship analysis was made with endpoints revision for any reason and aseptic loss of biological fixation. RESULTS: One hundred and thirty-six TKAs implanted in 113 patients were available for analysis. Mean KSCRS clinical and functional scores improved significantly versus preoperative values. No radiological loss of biological fixation of femoral and tibial components was observed. Survival with aseptic revision of any component as the endpoint was 95.7 % (95 % confidence interval (CI) 91.7-97.9 %) and 93.6 % (95 % CI 87.8-96.6 %) at 10 and 15 years, respectively. CONCLUSION: Titanium plasma-coated cementless TKA without patella resurfacing showed excellent long-term results, with high 10- and 15-year component survival rates. The clinical and radiological results were comparable to those of other cementless TKAs, providing further evidence for the non-cemented resurfacing of the osteoarthritic knee. LEVEL OF EVIDENCE: IV.
PURPOSE: While cemented total knee arthroplasty (TKA) is currently the gold standard for primary osteoarthritis, cementless component fixation has achieved increasingly comparable outcomes due to improvements in both implant designs and surgical technique. Long-term outcomes and survivorship with the TC-Plus cementless, titanium plasma-coated TKA system without patella resurfacing were evaluated. METHODS: A homogenous population of 171 consecutive patients who received 206 primary TC-Plus TKAs without patella resurfacing over a 19-year period was retrospectively reviewed. Knee Society Clinical Rating System (KSCRS) scores were obtained, and radiographic evaluation was performed after a mean follow-up of 13.2 ± 8.4 years. Survivorship analysis was made with endpoints revision for any reason and aseptic loss of biological fixation. RESULTS: One hundred and thirty-six TKAs implanted in 113 patients were available for analysis. Mean KSCRS clinical and functional scores improved significantly versus preoperative values. No radiological loss of biological fixation of femoral and tibial components was observed. Survival with aseptic revision of any component as the endpoint was 95.7 % (95 % confidence interval (CI) 91.7-97.9 %) and 93.6 % (95 % CI 87.8-96.6 %) at 10 and 15 years, respectively. CONCLUSION:Titanium plasma-coated cementless TKA without patella resurfacing showed excellent long-term results, with high 10- and 15-year component survival rates. The clinical and radiological results were comparable to those of other cementless TKAs, providing further evidence for the non-cemented resurfacing of the osteoarthritic knee. LEVEL OF EVIDENCE: IV.
Authors: Michael A Mont; Robert Pivec; Kimona Issa; Bhaveen H Kapadia; Aditya Maheshwari; Steven F Harwin Journal: J Knee Surg Date: 2013-12-07 Impact factor: 2.757
Authors: Travis R Flick; Cindy X Wang; Akshar H Patel; Thomas W Hodo; William F Sherman; Fernando L Sanchez Journal: J Orthop Traumatol Date: 2021-01-05
Authors: Christian Stadler; M Hofstätter; M Luger; M Stöbich; B Ruhs; T Gotterbarm; A Klasan Journal: Knee Surg Sports Traumatol Arthrosc Date: 2022-08-15 Impact factor: 4.114